Third Rock is dedicated to pushing the limits of science and technology in order to improve the lives of patients and their families. When they launched the company in 2007, they were enthralled by the prospect of turning scientific breakthroughs into game-changing drugs. They invented a process that had never been done before in order to accomplish what had never been done before. They set out to do more than fund startups by starting with big ideas and enabling collaboration among great people with skills in research, medicine, business, and strategy. They want to establish sustainable, innovative firms that can alter the lives of patients. Pliant is setting the standard to satisfy the unmet medical requirements of physicians, patients, and families affected by fibrotic disease. It was founded by Third Rock Ventures alongside world-renowned academic thought leaders. The company's main focus is on small molecule-based mechanism-based intervention in the fibrotic process.
LENSA generates certain information provided on this website by compiling and analyzing publicly available data and data from employees/former employees. All company names are the registered trademarks of their original owners. The use of any trade name or trademark does not imply any association with the third-party company. None of the information provided is endorsed in any way by any of the companies mentioned. We do not guarantee the accuracy, currency, or suitability of this information (including regarding demographics or salary estimate) and you are responsible for how you use it. ALL INFORMATION IS PROVIDED “AS IS” AND “WITH ALL FAULTS”. We are not responsible for nor endorse third party content on our website. If you notice any inaccurate information or information you think is proprietary you can email us at [email protected]. See our Terms and Conditions and Community Guidelines for more information.
How do I match this company?
